Skip to main content

. 1958 Mar;51(3):183–200. doi: 10.1177/003591575805100312

The Calcium-containing Renal Stone

PMCID: PMC1889586 PMID: 19993955

183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ALBRIGHT F., CARROLL E. L., DEMPSEY E. F., HENNEMAN P. H. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J Clin Invest. 1956 Nov;35(11):1229–1242. doi: 10.1172/JCI103378. [DOI] [PMC free article] [PubMed] [Google Scholar]
ANDERSON J., HARPER C., DENT C. E., PHILPOT G. R. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia; possibly antagonistic actions of cortisone and vitamin D. Lancet. 1954 Oct 9;267(6841):720–724. doi: 10.1016/s0140-6736(54)90492-4. [DOI] [PubMed] [Google Scholar]
ARCHER H. E., DORMER A. E., SCOWEN E. F., WATTS R. W. Primary hyperoxaluria. Lancet. 1957 Aug 17;273(6990):320–322. doi: 10.1016/s0140-6736(57)92210-9. [DOI] [PubMed] [Google Scholar]
BAKER R., SISON F. Demonstration of altered tissue mucopolysaccharides in renal calculus disease by selective staining techniques. J Urol. 1954 Dec;72(6):1032–1045. doi: 10.1016/S0022-5347(17)67712-7. [DOI] [PubMed] [Google Scholar]
CARE A. D., WILSON G. The prevention of vesical calculi in rats by the oral administration of polysodium metaphosphate. Clin Sci. 1956 May;15(2):183–192. [PubMed] [Google Scholar]
COTTET J., VITTU C. Calcium urinaire et lithiases urinaires. Presse Med. 1955 Jun 8;63(42):878–879. [PubMed] [Google Scholar]
DENT C. E., SENIOR B. Studies on the treatment of cystinuria. Br J Urol. 1955 Dec;27(4):317–332. doi: 10.1111/j.1464-410x.1955.tb03486.x. [DOI] [PubMed] [Google Scholar]
FRANKS L. M. Latent carcinoma. Ann R Coll Surg Engl. 1954 Oct;15(4):236–249. [PMC free article] [PubMed] [Google Scholar]
GROVE W. J., VERMEULEN C. W., GOETZ R., RAGINS H. D. Experimental urolithiasis. II. The influence of urine volume upon calculi experimentally produced upon foreign bodies. J Urol. 1950 Oct;64(4):549–554. doi: 10.1016/S0022-5347(17)68675-0. [DOI] [PubMed] [Google Scholar]
MANDL I., GRAUER A., NEUBERG C. Solubilization of insoluble matter in nature. II. The part played by salts of organic and inorganic acids occurring in nature. Biochim Biophys Acta. 1953 Apr;10(4):540–569. doi: 10.1016/0006-3002(53)90298-4. [DOI] [PubMed] [Google Scholar]
MCGEOWN M. G., BULL G. M. The pathogenesis of urinary calculus formation. Br Med Bull. 1957 Jan;13(1):53–57. doi: 10.1093/oxfordjournals.bmb.a069571. [DOI] [PubMed] [Google Scholar]
NICOLAYSEN R., EEG-LARSEN N., MALM O. J. Physiology of calcium metabolism. Physiol Rev. 1953 Jul;33(3):424–444. doi: 10.1152/physrev.1953.33.3.424. [DOI] [PubMed] [Google Scholar]
PRIEN E. L., WALKER B. S. Studies in urolithiasis. IV. Urinary glucuronosides and calcium phosphate. J Urol. 1955 Oct;74(4):440–446. doi: 10.1016/S0022-5347(17)67303-8. [DOI] [PubMed] [Google Scholar]
PYRAH L. N., RAPER F. P., SMITH I. B. The use of aluminium hydroxide to prevent recurrent renal calculi. Br J Urol. 1956 Sep;28(3):231–239. doi: 10.1111/j.1464-410x.1956.tb04761.x. [DOI] [PubMed] [Google Scholar]
SUTHERLAND J. W. Recurrence following operations for upper urinary tract stone. Br J Urol. 1954 Mar;26(1):22–45. doi: 10.1111/j.1464-410x.1954.tb04732.x. [DOI] [PubMed] [Google Scholar]
VERMEULEN C. W., FINLAYSON B., CHAPMAN W. Influence of urinary glucuronide on solubility of calcium phosphate and stone formation: experimental urolithiasis. XII. J Urol. 1957 May;77(5):685–696. doi: 10.1016/S0022-5347(17)66619-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES